These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 35778780)

  • 21. Vitamin D reduces eosinophilic airway inflammation in nonatopic asthma.
    de Groot JC; van Roon EN; Storm H; Veeger NJ; Zwinderman AH; Hiemstra PS; Bel EH; ten Brinke A
    J Allergy Clin Immunol; 2015 Mar; 135(3):670-5.e3. PubMed ID: 25617224
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical and inflammatory features of asthma with dissociation between fractional exhaled nitric oxide and eosinophils in induced sputum.
    Crespo A; Giner J; Torrejón M; Belda A; Mateus E; Granel C; Torrego A; Ramos-Barbón D; Plaza V
    J Asthma; 2016 Jun; 53(5):459-64. PubMed ID: 26785727
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fractional Exhaled Nitric Oxide Guided-Therapy in Chronic Obstructive Pulmonary Disease: A Stratified, Randomized, Controlled Trial.
    Su KC; Ko HK; Hsiao YH; Chou KT; Chen YW; Yu WK; Pan SW; Feng JY; Perng DW
    Arch Bronconeumol; 2022 Aug; 58(8):601-610. PubMed ID: 35312525
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Potentially pathogenic airway bacteria and neutrophilic inflammation in treatment resistant severe asthma.
    Green BJ; Wiriyachaiporn S; Grainge C; Rogers GB; Kehagia V; Lau L; Carroll MP; Bruce KD; Howarth PH
    PLoS One; 2014; 9(6):e100645. PubMed ID: 24955983
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of Anti-T2 Biologic Treatment on Lung Ventilation Evaluated by MRI in Adults With Prednisone-Dependent Asthma.
    Svenningsen S; Eddy RL; Kjarsgaard M; Parraga G; Nair P
    Chest; 2020 Oct; 158(4):1350-1360. PubMed ID: 32428511
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Weight-adjusted Intravenous Reslizumab in Severe Asthma with Inadequate Response to Fixed-Dose Subcutaneous Mepolizumab.
    Mukherjee M; Aleman Paramo F; Kjarsgaard M; Salter B; Nair G; LaVigne N; Radford K; Sehmi R; Nair P
    Am J Respir Crit Care Med; 2018 Jan; 197(1):38-46. PubMed ID: 28915080
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Longitudinal Impact of Sputum Inflammatory Phenotypes on Small Airway Dysfunction and Disease Outcomes in Asthma.
    Abdo M; Pedersen F; Kirsten AM; Veith V; Biller H; Trinkmann F; von Mutius E; Kopp M; Hansen G; Rabe KF; Bahmer T; Watz H;
    J Allergy Clin Immunol Pract; 2022 Jun; 10(6):1545-1553.e2. PubMed ID: 35257957
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Association between fractional exhaled nitric oxide, sputum induction and peripheral blood eosinophil in uncontrolled asthma.
    Gao J; Wu F
    Allergy Asthma Clin Immunol; 2018; 14():21. PubMed ID: 29796021
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mepolizumab Effectiveness and Allergic Status in Real Life.
    Sposato B; Scalese M; Camiciottoli G; Carpagnano GE; Pelaia C; Santus P; Maniscalco M; Corsico A; Grosso A; Baglioni S; Murgia N; Folletti I; Pelaia G; Masieri S; Cavaliere C; Musarra A; Bargagli E; Ricci A; Latorre M; Paggiaro P; Rogliani P
    Int Arch Allergy Immunol; 2021; 182(4):311-318. PubMed ID: 33113532
    [TBL] [Abstract][Full Text] [Related]  

  • 30. CT and Functional MRI to Evaluate Airway Mucus in Severe Asthma.
    Svenningsen S; Haider E; Boylan C; Mukherjee M; Eddy RL; Capaldi DPI; Parraga G; Nair P
    Chest; 2019 Jun; 155(6):1178-1189. PubMed ID: 30910637
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Multidimensional Assessment of Asthma Identifies Clinically Relevant Phenotype Overlap: A Cross-Sectional Study.
    Han YY; Zhang X; Wang J; Wang G; Oliver BG; Zhang HP; Kang Y; Wang L; Qiu ZX; Li WM; Wang G
    J Allergy Clin Immunol Pract; 2021 Jan; 9(1):349-362.e18. PubMed ID: 32791248
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Airway microbiota and immune mediator relationships differ in obesity and asthma.
    Kozik AJ; Begley LA; Lugogo N; Baptist A; Erb-Downward J; Opron K; Huang YJ
    J Allergy Clin Immunol; 2023 Apr; 151(4):931-942. PubMed ID: 36572355
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Diagnosis and Management of T2-High Asthma.
    Coverstone AM; Seibold MA; Peters MC
    J Allergy Clin Immunol Pract; 2020 Feb; 8(2):442-450. PubMed ID: 32037108
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Disconnect of type 2 biomarkers in severe asthma; dominated by FeNO as a predictor of exacerbations and periostin as predictor of reduced lung function.
    Mansur AH; Srivastava S; Sahal A
    Respir Med; 2018 Oct; 143():31-38. PubMed ID: 30261989
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Airway remodelling rather than cellular infiltration characterizes both type2 cytokine biomarker-high and -low severe asthma.
    Khalfaoui L; Symon FA; Couillard S; Hargadon B; Chaudhuri R; Bicknell S; Mansur AH; Shrimanker R; Hinks TSC; Pavord ID; Fowler SJ; Brown V; McGarvey LP; Heaney LG; Austin CD; Howarth PH; Arron JR; Choy DF; Bradding P
    Allergy; 2022 Oct; 77(10):2974-2986. PubMed ID: 35579040
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Role of local eosinophilopoietic processes in the development of airway eosinophilia in prednisone-dependent severe asthma.
    Sehmi R; Smith SG; Kjarsgaard M; Radford K; Boulet LP; Lemiere C; Prazma CM; Ortega H; Martin JG; Nair P
    Clin Exp Allergy; 2016 Jun; 46(6):793-802. PubMed ID: 26685004
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tailoring asthma treatment on eosinophilic markers (exhaled nitric oxide or sputum eosinophils): a systematic review and meta-analysis.
    Petsky HL; Cates CJ; Kew KM; Chang AB
    Thorax; 2018 Dec; 73(12):1110-1119. PubMed ID: 29858277
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A study to evaluate safety and efficacy of mepolizumab in patients with moderate persistent asthma.
    Flood-Page P; Swenson C; Faiferman I; Matthews J; Williams M; Brannick L; Robinson D; Wenzel S; Busse W; Hansel TT; Barnes NC;
    Am J Respir Crit Care Med; 2007 Dec; 176(11):1062-71. PubMed ID: 17872493
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Characteristics associated with clinical severity and inflammatory phenotype of naturally occurring virus-induced exacerbations of asthma in adults.
    Bjerregaard A; Laing IA; Poulsen N; Backer V; Sverrild A; Fally M; Khoo SK; Barrett L; Baltic S; Thompson PJ; Chidlow G; Sikazwe C; Smith DW; Bochkov YA; Le Souëf P; Porsbjerg C
    Respir Med; 2017 Feb; 123():34-41. PubMed ID: 28137494
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inflammatory phenotypes in patients with severe asthma are associated with distinct airway microbiology.
    Taylor SL; Leong LEX; Choo JM; Wesselingh S; Yang IA; Upham JW; Reynolds PN; Hodge S; James AL; Jenkins C; Peters MJ; Baraket M; Marks GB; Gibson PG; Simpson JL; Rogers GB
    J Allergy Clin Immunol; 2018 Jan; 141(1):94-103.e15. PubMed ID: 28479329
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.